Respiratory Viral Articles & Analysis
8 articles found
Welcome to 2023-2024 season’s respiratory surveillance recap, where we’ll share insights from the most recent respiratory surveillance season, covering three major respiratory viruses: COVID-19, influenza, and RSV. Tracking these illnesses is imperative for maintaining population health because these illnesses significantly impact ...
Zapnometinib has been developed for the treatment of severe respiratory viral infections with complications of hyperinflammation. The antiviral activity of zapnometinib treatment has been demonstrated for influenza virus infection in vivo (Laure et al., 2020; Koch-Heier et al., 2022) and influenza virus and severe acute respiratory syndrome ...
The rise in prevalence of viral respiratory infections in humans and increase in health care expenditure are projected to boost the growth of the global respiratory antiviral treatment market. Respiratory syncytial virus, influenza virus, parainfluenza virus, adenovirus, rhinovirus, and coronavirus belong to the ...
Some experts have indicated that mucosal immunization of the respiratory system with an inhaled form of the vaccine may be more efficient in dealing with the Omicron strain in light of recent results that demonstrate Omicron infections are more concentrated in the upper respiratory tract. ...
Researchers from Nanyang Technological University and its Center for 3D printing (SC3DP) have developed a 3D printed a highly repeatable and scalable three-dimensional in-vitro alveolar lung model using our REGENHU bioprinter, that could be exploited for pathogen translocation studies and respiratory-related toxicological testing applications. The triple-cell layered lung model ...
ByRegenhu
Abstract Rationale:Patients with severe coronavirus disease (COVID-19) require supplemental oxygen and ventilatory support. It is unclear whether some respiratory support devices may increase the dispersion of infectious bioaerosols and thereby place healthcare workers at increased risk of infection with severe acute respiratory syndrome coronavirus 2 ...
Now identified as severe acute respiratory syndrome or SARS, this highly contagious condition is caused by a new coronavirus for which there is no specific antiviral treatment. ...
Worldwide annually there are 1.7 million deaths from diarrheal diseases and 1.5 million deaths from respiratory infections (56). Viruses cause an estimated 60% of human infections, and most common illnesses are produced by respiratory and enteric viruses (7, 49). Unlike bacterial disease, viral illness cannot be resolved with the use of ...